Packaging & Labelling
News
Jicon, single-point for pharma and packaging machinery
Founded in 1984, Jicon is a pharmaceutical processing and packaging equipment manufacturer based in Mumbai. From its Bhiwandi plant in suburban Mumbai, it supplies capital equipment for making tablets, capsules, and ointments to pharma formulation plants.
Karan Hemani, a partner...
Packaging & Labelling
Emirates SkyCargo strengthens its pharma corridors initiative with fit-for-purpose infrastructure
With over 75,000 tonnes of pharmaceuticals flown across the world during the Financial Year 2018/19, Emirates SkyCargo is one of the leading international players in the air transportation of pharmaceuticals. Over the years, the freight division of Emirates has...
Packaging & Labelling
Turkish Cargo is entitled to “TAPA FSR” security certificate
The global air cargo brand, Turkish Cargo, is entitled to "GROUP A TAPA (Transported Asset Protection Association) FSR" certificate founded to reduce the loss in the international supply chain and based on the security of facilities.
TÜV Rheinland, providing independent...
Packaging & Labelling
FDA approves Activ-Blister packaging solution for oral solid dose HIV prevention medicine
The system protects oral solid drug products with a 3-Phase Activ-Polymer solution that is fully integrated into the blister package.
AptarGroup has announced that its Activ-Blister packaging solution for oral solid dose drug delivery has been approved by the FDA...
News
Catalent To Debate Logistics Of Delivery And Transportation Of Cell And Gene Therapies At HPCLC
Catalent, a global leader in clinical supply services, announced that Ann McMahon, Program Director, Clinical Supply Services and Drug Product Technologies Integration, will participate in a panel session titled “ Cell and Gene Therapy Logistics ” at the upcoming...
Packaging & Labelling
Aptars Activ Blister Packaging Solution Approved by U.S. FDA for Oral Solid Dose HIV Prevention Medicine
Aptar announced that its Activ-Blister packaging solution for oral solid dose drug delivery was recently approved by the U.S. FDA for a HIV prevention medicine.
The oral solid dose drug was developed by a leading pharmaceutical company in the HIV...
Packaging & Labelling
Vertex Wins Approval for Triple Combination Drug Expected to Treat 90% of CF Patients
The U.S. FDA approved a new cystic fibrosis medication that is expected to provide treatment for 90% of patients with this debilitating and life-shortening condition. Late Monday, the FDA greenlit Vertex Pharmaceuticals’ Trikafta.
Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) was approved for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.